We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

1 hedge funds and large institutions have $34.3M invested in Ariad Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 191 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding in top 10

Funds holding in top 10: 9 → 1 (-8)

98% less capital invested

Capital invested by funds: $2.13B → $34.3M (-$2.09B)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 191

100% less funds holding

Funds holding: 200 → 1 (-199)

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
191
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$16.5M

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$225M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$218M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$182M
4
SCM
Sarissa Capital Management
Connecticut
-$160M
5
State Street
State Street
Massachusetts
-$97.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
176
Perceptive Advisors
New York
– -$19K -1,551 Closed
Fifth Third Bancorp
177
Fifth Third Bancorp
Ohio
– -$19K -1,500 Closed
MFW
178
Mosaic Family Wealth
Missouri
– -$18K -1,475 Closed
PHK
179
Point72 Hong Kong
Hong Kong
– -$14K -1,152 Closed
QCG
180
Quadrant Capital Group
Ohio
– -$11K -889 Closed
FNBT
181
FineMark National Bank & Trust
Florida
– -$10K -800 Closed
TCOV
182
Trust Company of Vermont
Vermont
– -$8K -650 Closed
GXMC
183
Global X Management Company
New York
– -$8K -642 Closed
FANJ
184
Financial Architects (New Jersey)
New Jersey
– -$7K -600 Closed
Northwestern Mutual Wealth Management
185
Northwestern Mutual Wealth Management
Wisconsin
– -$6K -500 Closed
DADC
186
D.A. Davidson & Co
Montana
– -$4K -400 Closed
WA
187
WFG Advisors
Texas
– -$5K -400 Closed
HR
188
Howe & Rusling
New York
– -$4K -355 Closed
GRP
189
Global Retirement Partners
California
– -$2K -200 Closed
RFA
190
Reilly Financial Advisors
California
– -$2K -200 Closed
WAM
191
Wealthspire Advisors (Maryland)
Maryland
– -$2K -137 Closed
HMS
192
Hanseatic Management Services
New Mexico
– -$1K -86 Closed
4 5 6 7
8

ARIA Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2017, worth a combined $34.3M — down 98% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 191 funds closed out of ARIA and 1 opened new positions — a net loss of 190 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $225M sold.

  • 1 institutional investor held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2017, down from 200 in Q4 2016.
  • Funds reported $34.3M of Ariad Pharmaceuticals Inc stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Ariad Pharmaceuticals Inc positions in Q1 2017 and 191 closed out, a net change of -190 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $32M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $225M sold.

Based on aggregated 13F filings for Q1 2017.